COVIDIEN: technical information about the products

In ICU
Fri, 6 Nov 2009

Our company offers one of the largest portfolios of products designed to help reduce morbidity associated with Nosocomial Infections (NI) and specifically those affecting the respiratory tract.

Our mission is to work in partnership with healthcare professionals in order to win the race against hospital acquired infections and offer patients a fast and safe route to recover quickly.

- Products for Patient Safety

«« Rhesus Healthcare is pleased to announce it has formed a Joint Venture company with 3F Medical Systems.

Edwards Lifesciences and DexCom Announce Receipt of CE Mark for Glucose Monitoring System »»

Latest Articles

Decision-Making in the ICU
- ICU Journal Article
- 19/04/2024
Decision-making in the ICU is a multifaceted process that involves clinical assessment, collaboration among multidisciplinary teams, ethical considerations, evidence-based practice, communication, and continuous adaptation to evolving clinical scenarios. Balancing the complex factors requires
READ MORE
Dealing With Uncertainty in ICU Decision-Making: A Practical Guide
- ICU Journal Article
- 19/04/2024
When the stakes are high, and the path ahead is uncertain, the decisions made, especially if a patient continues to worsen, can be sources of self-torment and can haunt us for a long time. Our goal is to suggest ways to steer decision-making for intensivists in the face of uncertainty by prop
READ MORE
The Least Bad Decision: Crisis Standards of Care After the Pandemic
- ICU Journal Article
- 19/04/2024
COVID-19 was an emergency that lasted for years and left few regions of the world untouched. The pandemic shone a spotlight on both the strengths and weaknesses of our disaster planning. What worked, what did not, and how can we better plan for future emergencies? The COVID-19 pandemic fo
READ MORE

Our company offers one of the largest portfolios of products designed to help reduce morbidity associated with Nosocomial Infections (NI) and specificall...